Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
LABO DéESSE from Beveren-Kruibeke-Zwijndrecht, company number BE0755856068, closed financial year 2025 with a result of € -110,381 after tax. For that financial year LABO DéESSE recorded a gross margin of € -9,860 and equity of € -100,116. Compared with financial year 2024, the result moved from € -220,787 to € -110,381. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 20, 2026.
€ -100,116
▼ € 110,381 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -110,381
▲ 50 % less loss than in 2024
Profit after tax over the fiscal year.
€ 479,470
▲ 23% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -505,053.
People and assets in 2025
€ 36,658
▲ € 34,228 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,480
▲ € 2,227 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 358,410
▼ 4% vs 2024
€ 24,701 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 255,770
▲ € 216,626 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 58,955
▲ € 57,585 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -41,073 | € -66,056 | € -159,759 | € -9,860 | ▲ € 149,899 |
| Profit after taxes | € -63,506 | € -110,380 | € -220,787 | € -110,381 | ▲ € 110,406 |
| Equity | € -33,506 | € -143,886 | € 10,265 | € -100,116 | ▼ € 110,381 |
| Total debts | € 176,771 | € 342,689 | € 639,050 | € 899,313 | ▲ 41% |
| Cash | € 11,588 | € 20,159 | € 391,069 | € 479,470 | ▲ 23% |
| Retained profit | € -63,506 | € -173,886 | € -394,673 | € -505,053 | ▼ € 110,381 |
| Bank debt | € 40,000 | € 107,000 | € 372,633 | € 358,410 | ▼ 4% |
| Balance sheet total | € 143,265 | € 198,803 | € 649,315 | € 799,197 | ▲ 23% |
Key figures of LABO DéESSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LABO DéESSE?
What happened at LABO DéESSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Mira De Maeyer stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 110,381. Source: NBB ↗
- Mira De Maeyer became a director. NBB
- Joris Mortelmans became a director. NBB
- Aude Helleputte became a director. NBB
- Karl-Filip Smet became a director. NBB
- New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,506 loss in 2022 to € 110,381 loss in 2025.
Paid € 55 in corporate taxes since 2022.
A new publication or filing at LABO DéESSE? We notify you, reason included.
Follow LABO DéESSEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind LABO DéESSE are Joris Mortelmans, Aude Helleputte and Karl-Filip Smet. Joris Mortelmans is also behind VERAN, FICOMOR, DE KOOLPUTTEN, Korte Winkel and Heran Partners.
Directors
According to the 2025 annual accounts
Joris Mortelmans
Director
Also active at: VERAN, FICOMOR, DE KOOLPUTTEN, Korte Winkel, Heran Partners, OPDORP FINANCE
since 2024
Aude Helleputte
Director
since 2024
Karl-Filip Smet
Director
since 2024
Mira De Maeyer
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Belgium, BIOVER, Oce-Bio, JAICO R.D.P., HRA PHARMA BENELUX, OMEGA PHARMA INTERNATIONAL, Belgian Association of Consumer Healthcare Industry +2 more
since 2024 · until 2027
Establishments
Establishment units
Physical locations of this company
Stationsstraat(BEV) 18
9120 Beveren-Kruibeke-Zwijndrecht
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0755.856.068
- VAT number
- BE 0755.856.068
- Registered office
- Stationsstraat(BEV) 18, 9120 Beveren-Kruibeke-Zwijndrecht
- Names & denominations
- LABO DéESSE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 October 2020
- Peppol
- Active · Active since 11 Mar 2025
- Activities · NACE
Vervaardiging van parfums en toiletartikelen
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels